日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PROX1 is an early driver of lineage plasticity in prostate cancer.

PROX1 是前列腺癌谱系可塑性的早期驱动因素

Duan Zhi, Shi Mingchen, Kumaraswamy Anbarasu, Lin Dong, Khokhani Dhruv, Wang Yong, Zhang Chao, Flores Diana, Rodansky Eva, Swaim Olivia A, Storck William K, Beck Hannah N, Patel Radhika A, Sayar Erolcan, Hanratty Brian P, Xue Hui, Dong Xin, Maylin Zoe R, Wan Rensheng, Quigley David A, Sjöström Martin, Hu Ya-Mei, Zhao Faming, Xia Zheng, Cheng Siyuan, Yu Xiuping, Feng Felix Y, Zhang Li, Aggarwal Rahul, Small Eric J, Ravikumar Visweswaran, Rao Arvind, Bedi Karan, Lee John K, Morrissey Colm, Coleman Ilsa, Nelson Peter S, Corey Eva, Udager Aaron M, Rebernick Ryan J, Cieslik Marcin P, Chinnaiyan Arul M, Yates Joel A, Haffner Michael C, Wang Yuzhuo, Alumkal Joshi J

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

转录组分析揭示了致命性前列腺癌中恩扎卢胺极度无反应的机制

Kumaraswamy Anbarasu, Hu Ya-Mei, Yates Joel A, Zhang Chao, Rodansky Eva, Khokhani Dhruv, Flores Diana, Duan Zhi, Zhang Yi, Tabatabaei Shaadi, Slottke Rachel, Ye Shangyuan, Lara Primo, Foye Adam, Ryan Charles J, Quigley David A, Huang Jiaoti, Aggarwal Rahul, Reiter Robert E, Wicha Max S, Beer Tomasz M, Rettig Matthew, Gleave Martin, Evans Christopher P, Witte Owen N, Stuart Joshua M, Thomas George V, Feng Felix Y, Small Eric J, Xia Zheng, Alumkal Joshi J

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer.

LSD1+8a 是神经内分泌前列腺癌的 RNA 生物标志物

Kumaraswamy Anbarasu, Mannan Rahul, Swaim Olivia A, Rodansky Eva, Wang Xiao-Ming, Udager Aaron, Mehra Rohit, Li Hui, Morrissey Colm, Corey Eva, Haffner Michael C, Nelson Peter S, Chinnaiyan Arul M, Yates Joel A, Alumkal Joshi J

LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function

LSD1 通过抑制 TP53 信号来促进前列腺癌重编程,而不依赖于其去甲基化酶功能

Anbarasu Kumaraswamy, Zhi Duan, Diana Flores, Chao Zhang, Archana Sehrawat, Ya-Mei Hu, Olivia A Swaim, Eva Rodansky, William K Storck, Joshua A Kuleape, Karan Bedi, Rahul Mannan, Xiao-Ming Wang, Aaron Udager, Visweswaran Ravikumar, Armand Bankhead 3rd, Ilsa Coleman, John K Lee, Colm Morrissey, Peter

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity

匹配患者活检的转录分析阐明了恩杂鲁胺诱导的谱系可塑性的分子决定因素

Thomas C Westbrook #, Xiangnan Guan #, Eva Rodansky, Diana Flores, Chia Jen Liu, Aaron M Udager, Radhika A Patel, Michael C Haffner, Ya-Mei Hu, Duanchen Sun, Tomasz M Beer, Adam Foye, Rahul Aggarwal, David A Quigley, Jack F Youngren, Charles J Ryan, Martin Gleave, Yuzhuo Wang, Jiaoti Huang, Ilsa Col

Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model

ABT-263 对人类肌成纤维细胞、人类肠道类器官和小鼠鼠伤寒沙门氏菌模型中肠道纤维化的影响

Laura A Johnson, Eva S Rodansky, Anhdao Tran, Stephen G Collins, Kathryn A Eaton, Benjamin Malamet, Calen A Steiner, Sha Huang, Jason R Spence, Peter D R Higgins

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.

BET溴结构域抑制剂阻断了AR抑制、E2F1激活的治疗后出现的神经内分泌前列腺癌谱系可塑性程序

Kim Dae-Hwan, Sun Duanchen, Storck William K, Welker Leng Katherine, Jenkins Chelsea, Coleman Daniel J, Sampson David, Guan Xiangnan, Kumaraswamy Anbarasu, Rodansky Eva S, Urrutia Joshua A, Schwartzman Jacob A, Zhang Chao, Beltran Himisha, Labrecque Mark P, Morrissey Colm, Lucas Jared M, Coleman Ilsa M, Nelson Peter S, Corey Eva, Handelman Samuel K, Sexton Jonathan Z, Aggarwal Rahul, Abida Wassim, Feng Felix Y, Small Eric J, Spratt Daniel E, Bankhead Armand 3rd, Rao Arvind, Gesner Emily M, Attwell Sarah, Lakhotia Sanjay, Campeau Eric, Yates Joel A, Xia Zheng, Alumkal Joshi J

AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

AXL 是治疗肠道纤维化的潜在靶点

Calen A Steiner, Eva S Rodansky, Laura A Johnson, Jeffrey A Berinstein, Kelly C Cushing, Sha Huang, Jason R Spence, Peter D R Higgins

Optimisation of Intestinal Fibrosis and Survival in the Mouse S. Typhimurium Model for Anti-fibrotic Drug Discovery and Preclinical Applications

优化小鼠沙门氏菌模型中的肠道纤维化和存活率,以用于抗纤维化药物的发现和临床前应用

Johnson, Laura A; Rodansky, Eva S; Moons, David S; Larsen, Scott D; Neubig, Richard R; Higgins, Peter D R

Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis

抑制心肌相关转录因子/血清反应因子信号传导可减少肺纤维化并促进间充质细胞凋亡

Sisson, Thomas H; Ajayi, Iyabode O; Subbotina, Natalya; Dodi, Amos E; Rodansky, Eva S; Chibucos, Lauren N; Kim, Kevin K; Keshamouni, Venkateshwar G; White, Eric S; Zhou, Yong; Higgins, Peter D R; Larsen, Scott D; Neubig, Richard R; Horowitz, Jeffrey C